-
-
-
-
-
-
-
Moderna (MRNA) Issues Update on Investigational RSV Vaccine
-
-
-
-
-
-
-
Fate Therapeutics (FATE) Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
-
-
-
-
-
-
-
Can-Fite BioPharma (CANF) Granted FDA IND Clearance for Namodenoson
-
-
-
-
-
-
-
Prime Medicine (PRME) Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease
-
-
-
-
-
-
-
COMPASS Pathways plc (CMPS) Reports Durable Improvements in Phase 2 Trial of COMP360
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency
-
-
-
-
-
-
-
Merus N.V. (MRUS) Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno
-
67,031 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.